Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials

BACKGROUND: In patients with migraine, overuse of acute medication, including migraine-specific medication (MSM) such as triptans and ergots, can lead to adverse health outcomes, including development of medication overuse headache. Here, we examined the effect of erenumab on reducing acute medicati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Headache Pain
Autores principales: Tepper, Stewart J, Ashina, Messoud, Reuter, Uwe, Hallström, Yngve, Broessner, Gregor, Bonner, Jo H, Picard, Hernan, Cheng, Sunfa, Chou, Denise E, Zhang, Feng, Klatt, Jan, Mikol, Daniel D
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Milan 2021
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8299690/
https://ncbi.nlm.nih.gov/pubmed/34301173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-021-01292-w
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares